Table 2.

Patient and clinic staff participant survey content.

Outcome	Patient participants					Clinic staff
	Baseline	1 montha	3 months	6 months	Baseline		6 months
Acceptabilityb	✓	N/Ac	N/A	✓	✓		✓
Feasibilityb	N/A	N/A	N/A	N/A	✓		✓
Appropriatenessb	N/A	N/A	N/A	N/A	✓		✓
PrEPd usee	✓	✓	✓	✓	N/A		N/A
Contraceptionf	✓	✓	✓	✓	N/A		N/A
Perceived HIV risk	✓		✓	✓	N/A		N/A
Reasons for initiating (or declining) PrEP	✓	N/A		✓	N/A		N/A
Number of sexual partnersg	✓	N/A	✓	✓	N/A		N/A
Condom use	✓	N/A	✓	✓	N/A		N/A
HIV status of partners	✓	N/A	✓	✓	N/A		N/A

^aThere is no month-1 visit for group-2 participants.

^bRefers to acceptability, feasibility, and appropriateness specific to etiologic sexually transmitted infection testing, assisted partner notification, and integration of sexually transmitted infection and pre-exposure prophylaxis services.

^cN/A: not applicable.

^dPrEP: pre-exposure prophylaxis.

^eAdherence to PrEP is asked to group-1 and group-3 participants and any group-2 participant who decides to initiate PrEP during the follow-up period. Reasons for discontinuation is asked to individuals with gaps in use or intended cessation of use.

^fAsked only to female participants.

^gAt baseline, participants are asked about partners in previous 6 months; during follow-up visits, participants are queried about the number of partners since their previous visit (regardless of interval) and in the past month.